Cargando…
Clinical laboratory as an economic model for business performance analysis
AIM: To perform SWOT (strengths, weaknesses, opportunities, and threats) analysis of a clinical laboratory as an economic model that may be used to improve business performance of laboratories by removing weaknesses, minimizing threats, and using external opportunities and internal strengths. METHOD...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Medical Schools
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160698/ https://www.ncbi.nlm.nih.gov/pubmed/21853546 http://dx.doi.org/10.3325/cmj.2011.52.513 |
_version_ | 1782210575691939840 |
---|---|
author | Buljanović, Vikica Patajac, Hrvoje Petrovečki, Mladen |
author_facet | Buljanović, Vikica Patajac, Hrvoje Petrovečki, Mladen |
author_sort | Buljanović, Vikica |
collection | PubMed |
description | AIM: To perform SWOT (strengths, weaknesses, opportunities, and threats) analysis of a clinical laboratory as an economic model that may be used to improve business performance of laboratories by removing weaknesses, minimizing threats, and using external opportunities and internal strengths. METHODS: Impact of possible threats to and weaknesses of the Clinical Laboratory at Našice General County Hospital business performance and use of strengths and opportunities to improve operating profit were simulated using models created on the basis of SWOT analysis results. The operating profit as a measure of profitability of the clinical laboratory was defined as total revenue minus total expenses and presented using a profit and loss account. Changes in the input parameters in the profit and loss account for 2008 were determined using opportunities and potential threats, and economic sensitivity analysis was made by using changes in the key parameters. The profit and loss account and economic sensitivity analysis were tools for quantifying the impact of changes in the revenues and expenses on the business operations of clinical laboratory. RESULTS: Results of simulation models showed that operational profit of €470 723 in 2008 could be reduced to only €21 542 if all possible threats became a reality and current weaknesses remained the same. Also, operational gain could be increased to €535 804 if laboratory strengths and opportunities were utilized. If both the opportunities and threats became a reality, the operational profit would decrease by €384 465. CONCLUSION: The operational profit of the clinical laboratory could be significantly reduced if all threats became a reality and the current weaknesses remained the same. The operational profit could be increased by utilizing strengths and opportunities as much as possible. This type of modeling may be used to monitor business operations of any clinical laboratory and improve its financial situation by implementing changes in the next fiscal period. |
format | Online Article Text |
id | pubmed-3160698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Croatian Medical Schools |
record_format | MEDLINE/PubMed |
spelling | pubmed-31606982011-08-24 Clinical laboratory as an economic model for business performance analysis Buljanović, Vikica Patajac, Hrvoje Petrovečki, Mladen Croat Med J Clinical Science AIM: To perform SWOT (strengths, weaknesses, opportunities, and threats) analysis of a clinical laboratory as an economic model that may be used to improve business performance of laboratories by removing weaknesses, minimizing threats, and using external opportunities and internal strengths. METHODS: Impact of possible threats to and weaknesses of the Clinical Laboratory at Našice General County Hospital business performance and use of strengths and opportunities to improve operating profit were simulated using models created on the basis of SWOT analysis results. The operating profit as a measure of profitability of the clinical laboratory was defined as total revenue minus total expenses and presented using a profit and loss account. Changes in the input parameters in the profit and loss account for 2008 were determined using opportunities and potential threats, and economic sensitivity analysis was made by using changes in the key parameters. The profit and loss account and economic sensitivity analysis were tools for quantifying the impact of changes in the revenues and expenses on the business operations of clinical laboratory. RESULTS: Results of simulation models showed that operational profit of €470 723 in 2008 could be reduced to only €21 542 if all possible threats became a reality and current weaknesses remained the same. Also, operational gain could be increased to €535 804 if laboratory strengths and opportunities were utilized. If both the opportunities and threats became a reality, the operational profit would decrease by €384 465. CONCLUSION: The operational profit of the clinical laboratory could be significantly reduced if all threats became a reality and the current weaknesses remained the same. The operational profit could be increased by utilizing strengths and opportunities as much as possible. This type of modeling may be used to monitor business operations of any clinical laboratory and improve its financial situation by implementing changes in the next fiscal period. Croatian Medical Schools 2011-08 /pmc/articles/PMC3160698/ /pubmed/21853546 http://dx.doi.org/10.3325/cmj.2011.52.513 Text en Copyright © 2011 by the Croatian Medical Journal. All rights reserved. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Science Buljanović, Vikica Patajac, Hrvoje Petrovečki, Mladen Clinical laboratory as an economic model for business performance analysis |
title | Clinical laboratory as an economic model for business performance analysis |
title_full | Clinical laboratory as an economic model for business performance analysis |
title_fullStr | Clinical laboratory as an economic model for business performance analysis |
title_full_unstemmed | Clinical laboratory as an economic model for business performance analysis |
title_short | Clinical laboratory as an economic model for business performance analysis |
title_sort | clinical laboratory as an economic model for business performance analysis |
topic | Clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160698/ https://www.ncbi.nlm.nih.gov/pubmed/21853546 http://dx.doi.org/10.3325/cmj.2011.52.513 |
work_keys_str_mv | AT buljanovicvikica clinicallaboratoryasaneconomicmodelforbusinessperformanceanalysis AT patajachrvoje clinicallaboratoryasaneconomicmodelforbusinessperformanceanalysis AT petroveckimladen clinicallaboratoryasaneconomicmodelforbusinessperformanceanalysis |